: iStockAnalyst.com Symbols Feed

Two Stocks And An ETF Fom The Blogosphere

Tue, 12 May 2009 13:24:23 GMT

Running through my various blogger feeds and picked out a few stocks receiving attention. (1) NABI Biopharmaceuticals ($NABI) from X3 ETF Hell. CPL says: Anycase, since they revised their quarterly results it's appearently in worse shape than previously thought. I'm expecting tha it's going to challenge it's 52 week low. If the market is switching into back to basics investing. Poorly recieved results will be punished and with nothing really holding this market up except hope and faith if enough bad quarters are reported, the bottom should drop out again. Until then, keep an eye on this one. [More...]

New Preventive Medicine Index

Sun, 25 Jan 2009 18:49:00 GMT

One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies[More...]

Five Top Rated Preventive Medicine Stocks

Tue, 30 Dec 2008 02:06:00 GMT

The accompanying table (click to enlarge) presents statistics and the top five rated companies in the ETF Innovators (ETFI) Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $150M-$45B which are engaged in healthcare business segments including diabetes care companies such as Novo Nordisk (NVO), vaccine makers such as Nabi Biopharma (NABI), diagnostics companies such as China Medical (CMED), and lab services companies such as LabCorp (LH).[More...]

Nine Stocks, Finally Some Decent Setups!

Mon, 25 Aug 2008 16:15:00 GMT

A few solid potential plays, gonna be hard for me considering this week I’m staying at a Buddhist Temple on Mt. Koya, hot springs resort near Mt. Fuji, then climbing the mountain itself, then flying to Canada on Thursday…but the setups are there, so those[More...]

Few Thoughts and a Look at the Earnings in the Coming Week

Mon, 28 Jul 2008 05:15:00 GMT

WITH RESPECT TO THE US’ GDP GROWTH, THE NATIONAL BUREAU OF ECONOMIC RESEARCH SEES A SIGNIFICANT DECLINE IN ECONOMIC ACTITIVY SPREAD ACROSS THE ECONOMY, WHICH WILL LAST MORE THAN A FEW MONTHS - WSJ - According to Robert Hall, economist at Stanford University, US economic data that has been reported provide (...)[More...]

Oil Stocks Selling Off and a Decent Bear Market

Thu, 24 Jul 2008 03:54:00 GMT

Despite the fact that I have not been doing much the past week-plus thanks to Doctors orders to stay off my feet, there has been one event that has happened that makes me very happy, yet sad. Oil stocks coming off their highs on huge volume signals that we might have seen the top for oil stocks. I hope so personally as it would just be a lot healthier for the world markets if the stock market of the USA was doing well. The fact that there is weakness world wide will eventually lead to some great buying opportunities. As long as we have population growth, in the future, we should be moving higher as we go along our little lives.Those that have just recently gone long in the oil arena needs to realize they are going long a sector that has been in a cyclical uptrend since 2001. We are almost eight years into a very long bull market for oil stocks. It does appear that the top has come with the recent selloffs on the huge volume across the board on stocks like[More...]

Stock Ideas for Next Week

Sun, 18 May 2008 20:53:40 GMT

Last Saturday I posted some stocks I would be watching for Potential trend trades those stocks are in the table below. As much as I liked some of the setups, I did not expect the group to do as well as they did. The average stock on the list gained over 8[More...]

NASDAQ Technical Picture - Inside Day - Sep 6 2007 1:59AM

Thu, 06 Sep 2007 05:54:21 GMT

As noted in my post yesterday, the market was extended and some consolidation was anticipated. Weaker than expected data related to housing (Pending Home Sales drop 12.2%, biggest drop since stat began), jobs (ADP employment slowest in 4 yrs) and the usual loan loss estimates set the stage for some consolidation and sector profit taking. We had a minor bounce into the close as the 50 MA held as support on the first test.Companies moving in after hours trading...[More...]

NASDAQ Technical Picture - Bullish Hammer after a Strong Close

Thu, 02 Aug 2007 05:38:56 GMT

It was a slow day until we got that strong finish. The bulls and bears struggled all day, but the last half hour gave[More...]

StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals

Thu, 13 Aug 2009 12:38:00 GMT

StockPreacher.com announces an investment report featuring Nabi Biopharmaceuticals . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.[More...]

Nabi Biopharmaceuticals Announces Sale of PentaStaph(tm) to GlaxoSmithKline PLC

Thu, 06 Aug 2009 20:03:00 GMT

Nabi Biopharmaceuticals announced that it has signed a definitive agreement for the sale of PentaStaph and related assets to GlaxoSmithKline for a total consideration of up to $46 million. Under the terms of the agreement, Nabi will receive an initial cash payment of $20 million when the transaction closes plus an additional $26 million contingent upon four milestone accomplishments. The sale is subject to satisfaction of certain customary closing conditions by the buyer and seller prior to closing. Nabi anticipates closing the sale before year-end 2009 and completing the milestones within the next 18 months.[More...]

Nabi Biopharmaceuticals to Announce 2009 Second Quarter Financial Results on August 6, 2009

Tue, 28 Jul 2009 13:56:00 GMT

Nabi Biopharmaceuticals today announced that it will report its 2009 second quarter financial results on Thursday, August 6, 2009, after market close. The company will host a live webcast at 4:30 p.m. EDT that day to discuss these results.[More...]

Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales Conference

Mon, 13 Jul 2009 12:26:00 GMT

Jesup & Lamont, Inc., , a full-service boutique brokerage and investment banking firm serving retail and institutional clients, today announced the LifeTech Capital Group companies presenting at its 2009 Growth Stock & National Sales Conference to be held at the Waldorf Astoria Boca Beach Club on July 30th, 2009 in Boca Raton, Florida. In addition, former FDA Commissioner Dr. Lester M. Crawford D.V.M., Ph.D., will be the keynote speaker for the event.[More...]

Nabi Biopharmaceuticals Receives Scientific Advice On NicVAX(r) From the European Medicines Agency

Wed, 03 Jun 2009 11:56:00 GMT

Nabi Biopharmaceuticals announced it has received scientific advice from the European Medicines Agency on NicVAX regarding the requirements for marketing authorization submission as it relates to the appropriate design of the pivotal phase III clinical studies and safety data base . This advice helps ensure the performance of appropriate clinical studies so that no major objections regarding the design of the studies are likely to be raised during evaluation of the marketing authorization application. Following the EMEA's advice increases the probability of a positive outcome.[More...]

Nabi Biopharmaceuticals to Present At Noble Financial's Fifth Annual Equity Conference

Tue, 02 Jun 2009 14:36:00 GMT

Nabi Biopharmaceuticals today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial Capital Markets Fifth Annual Equity Conference held June 8-9, 2009 at the Hard Rock Hotel & Casino in Hollywood, Florida. Dr. Fahim's presentation is scheduled for June 8, 2009 at 4:50 p.m., EDT.[More...]

Nabi Biopharmaceuticals Announces Withdrawal of Biotest's Indemnification Claim

Mon, 01 Jun 2009 13:56:00 GMT

Nabi Biopharmaceuticals today announced that Biotest Pharmaceuticals Corporation has withdrawn and released a claim representing $50.4 million of the original $56 million indemnification claims made on March 31, 2009 against Nabi, and together with Nabi has instructed the escrow agent to release $4.5 million of the funds held in escrow to support indemnification claims. The withdrawn claim related to a contract assigned to Biotest when it purchased our biologics business unit in 2007.[More...]

Nabi Biopharmaceuticals Announces First Quarter 2009 Financial Results

Wed, 06 May 2009 20:02:00 GMT

Nabi Biopharmaceuticals today announced its first quarter financial results for the three month period ended March 28, 2009. The Company reported a net loss from continuing operations of $7.0 million, or $0.14 per share, compared to a net loss of $7.5 million, or $0.14 per share, for the period ended March 29, 2008. Including results from discontinued operations, Nabi had a net loss of $7.0 million, or $0.14 per share, for the current period compared to a net loss of $7.2 million, or $0.13 per share in the first quarter of 2008. The 2008 results have been adjusted to reflect the retrospective application of FSP 14-1 accounting rules for convertible debt instruments that were adopted in the first quarter of 2009.[More...]

Nabi Biopharmaceuticals to Announce 2009 First Quarter Financial Results On May 6, 2009

Tue, 28 Apr 2009 14:25:00 GMT

Nabi Biopharmaceuticals today announced that it will report its 2009 first quarter financial results on Wednesday, May 6, 2009, after market close. The company will host a live webcast at 4:30 p.m. EDT that day to discuss these results.[More...]

Nabi Biopharmaceuticals Announces Date for 2009 Annual Meeting of Shareholders

Wed, 01 Apr 2009 16:55:00 GMT

Nabi Biopharmaceuticals announced today that its 2009 Annual Meeting of Shareholders will be held on Friday, May 22, 2009 at 10:00 a.m. EDT. The location of the meeting will be the Bethesda Marriott Hotel, 5151 Pooks Hill Road in Bethesda, Maryland.[More...]